Previously we have documented a synergistic impact of recombinant-sCXCL16 on platelet-driven thrombotic response by acting through CXCR6 in experimental studies with human (in vitro) and murine systems (arterial thrombosis model in vivo) [8]. This evidence concerns the gene CXCR6 and Arterial thrombosis.